Close

Illumina (ILMN), ArcherDX Enter NGS-Based In Vitro Diagnostics Development Agreement

May 31, 2016 6:56 AM EDT Send to a Friend
ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login